C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/54 (2006.01) A61K 31/70 (2006.01) A61K 35/12 (2006.01) A61K 35/34 (2006.01) A61K 35/407 (2006.01) A61K 48/00 (2006.01) C12N 5/10 (2006.01) C12N 9/12 (2006.01) C12N 15/85 (2006.01)
Patent
CA 2236332
Process for treating a diabetic patient. The process comprises administering to the patient a DNA segment which includes a glucokinase gene and a promotor sequence. In the DNA segment, the promotor sequence is operatively linked to the glucokinase gene and is efficient for the expression of a therapeutically efficient quantity of glucokinase in the diabetic patient.
Procédé de traitement d'un patient diabétique. Le procédé consiste à administrer au patient un segment d'ADN qui comprend un gène de glucokinase et une séquence de promoteur. Dans le segment d'ADN, la séquence de promoteur est liée de manière effective au gène de glucokinase et est efficace pour l'expression d'une quantité thérapeutiquement efficace de glucokinase chez le patient souffrant de diabète.
Bosch Tubert Fatima
Valera Abril Alfons
Smart & Biggar
Universidad Autonoma de Barcelona
LandOfFree
Treatment of diabetes with a glucokinase gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diabetes with a glucokinase gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diabetes with a glucokinase gene will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1832922